L'intérêt à découvert pour AlphaPolis Co donne aux investisseurs une idée du degré auquel les investisseurs parient sur la baisse de l'action de AlphaPolis Co. Les données sur l'intérêt à découvert sont mises à jour toutes les deux semaines.

AlphaPolis Co (OTC:APPLF) Stock, Rapport sur les intérêts à découvert

AlphaPolis Co Ltd is engaged in the development, planning and sale of smartphone application and PC browser game. The company is also involved in the publication of books.

AlphaPolis Co Ltd

<a href="https://x.com/JStein_WaPo/status/1917220665821634689" title="https://x.com/JStein_WaPo/status/1917220665821634689">https://x.com/JStein_WaPo/status/1917220665821634689</a>

News

AMZN

Washington Post Reporter, Jeff Stein, On X Posts "Amazon Spox now saying this was never under consideration for the main Amazon website. Says Amazon Haul has considered listing import price duties on certain products"

UBS analyst Timothy Arcuri maintains Allegro Microsystems (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALGM#NASDAQ">ALGM</a>) with a Buy and lowers the price target from $30 to $22.

Price Target

Analyst Ratings

ALGM

UBS Maintains Buy on Allegro Microsystems, Lowers Price Target to $22

Stephens &amp; Co. analyst Michael Schmidt downgrades SpringWorks Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SWTX#NASDAQ">SWTX</a>) from Buy to Neutral and lowers the price target from $77 to $47.

Downgrades

SWTX

Stephens & Co. Downgrades SpringWorks Therapeutics to Neutral, Lowers Price Target to $47

UBS analyst Matheus Enfeldt maintains Adecoagro (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AGRO#NYSE">AGRO</a>) with a Neutral and lowers the price target from $10.5 to $9.9.

AGRO

UBS Maintains Neutral on Adecoagro, Lowers Price Target to $9.9

U.S. stocks were mixed, with the Dow Jones index gaining around 0.1% on Tuesday.
Shares of Honeywell International Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HON#NASDAQ">HON</a>) rose sharply during Tuesday's session after the company reported better-than-expected first-quarter financial results and <a href="https://www.benzinga.com/quote/HON/earnings">raised its FY25 adjusted EPS guidance</a>.
Revenue grew 8% year-over-year (Y/Y, organic: +4% Y/Y) to $9.82 billion, beating the consensus of $9.59 billion. Adjusted EPS was $2.51 (+7% Y/Y), beating the consensus of $2.21.
Honeywell International shares climbed 4.9% to $210.54 on Tuesday.
Here are some other big stocks recording gains in today's session.
<ul>
<li>Hims &amp; Hers Health, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HIMS#NYSE">HIMS</a>) shares jumped 23% to $34.99 after the company announced a collaboration with Novo Nordisk to offer a bundled package of all dose strengths of Wegovy on its platform.</li>
<li>Leggett &amp; Platt, Incorporated (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LEG#NYSE">LEG</a>) gained 21.1% to $8.81 after the company reported better-than-expected first-quarter EPS results and raised its FY25 EPS guidance.</li>
<li>Clarivate Plc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CLVT#NYSE">CLVT</a>) jumped 16.8% to $4.1950 after the company reported better-than-expected quarterly financial results.</li>
<li>Kiniksa Pharmaceuticals International, plc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KNSA#NASDAQ">KNSA</a>) jumped 16% to $24.90 as the company raised its FY2025 sales guidance.</li>
<li>CECO Environmental Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CECO#NASDAQ">CECO</a>) gained 15.7% to $22.22 following upbeat quarterly earnings.</li>
<li>LZ Technology Holdings Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LZMH#NASDAQ">LZMH</a>) rose 14.8% to $9.19.</li>
<li>ProPetro Holding Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PUMP#NYSE">PUMP</a>) shares rose 11.2% to $5.86 after the company reported a first-quarter adjusted EPS and revenue beat.</li>
<li>TriMas Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TRS#NYSE">TRS</a>) gained 11.2% to $23.34 following better-than-expected quarterly earnings.</li>
<li>Shift4 Payments, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FOUR#NYSE">FOUR</a>) gained 10.4% to $87.96 after the company reported better-than-expected first-quarter adjusted EPS results.</li>
<li>Metsera, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MTSR#NASDAQ">MTSR</a>) rose 10.2% to $21.83.</li>
<li>EPWK Holdings Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EPWK#NASDAQ">EPWK</a>) rose 9.4% to $15.00.</li>
<li>Crown Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CCK#NYSE">CCK</a>) gained 7% to $96.04 after the company reported better-than-expected quarterly financial results and raised its FY25 adjusted EPS guidance.</li>
<li>Noble Corporation plc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NE#NYSE">NE</a>) rose 6.4% to $22.36 after the company reported better-than-expected quarterly sales results.</li>
<li>Crane Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CR#NYSE">CR</a>) gained 5.3% to $156.47 following upbeat quarterly earnings.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/25/04/45064976/top-3-industrials-stocks-which-could-rescue-your-portfolio-in-q2">Top 3 Industrials Stocks Which Could Rescue Your Portfolio In Q2</a> </li>
</ul>
Photo via Shutterstock

Earnings

Intraday Update

Markets

Movers

CECO

CLVT

EPWK

FOUR

Hims & Hers Health, Inc. Class A Common Stock

HIMS

KNSA

LZMH

MTSR

PUMP

Honeywell Posts Better-Than-Expected Q1 Earnings, Joins Crown Holdings, Noble, Crane And Other Big Stocks Moving Higher On Tuesday

Piper Sandler analyst Frank Schiraldi maintains Meridian (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRBK#NASDAQ">MRBK</a>) with a Neutral and lowers the price target from $17 to $16.

MRBK

Piper Sandler Maintains Neutral on Meridian, Lowers Price Target to $16

UBS analyst Gavin Parsons maintains Woodward (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WWD#NASDAQ">WWD</a>) with a Buy and raises the price target from $200 to $220.

UBS Maintains Buy on Woodward, Raises Price Target to $220

DAAQU

Trading Halt: Halt status updated at 10:35:00 AM ET: Quotation Resumption: IPO Security - Released for Quotation

Piper Sandler analyst Nathan Race maintains First Savings Financial (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FSFG#NASDAQ">FSFG</a>) with a Overweight and raises the price target from $30 to $32.

FSFG

Piper Sandler Maintains Overweight on First Savings Financial, Raises Price Target to $32

UBS analyst Kevin Caliendo maintains McKesson (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MCK#NYSE">MCK</a>) with a Buy and raises the price target from $708 to $805.

UBS Maintains Buy on McKesson, Raises Price Target to $805

Piper Sandler analyst Nathan Race maintains First Northwest Bancorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FNWB#NASDAQ">FNWB</a>) with a Neutral and raises the price target from $11.5 to $12.

FNWB

Piper Sandler Maintains Neutral on First Northwest Bancorp, Raises Price Target to $12

UBS analyst Kunal Madhukar maintains eBay (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EBAY#NASDAQ">EBAY</a>) with a Neutral and raises the price target from $72 to $73.

EBAY

UBS Maintains Neutral on eBay, Raises Price Target to $73

UBS analyst Kevin Caliendo maintains Cencora (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/COR#NYSE">COR</a>) with a Buy and raises the price target from $298 to $335.

UBS Maintains Buy on Cencora, Raises Price Target to $335

Piper Sandler analyst Luke Lemoine maintains Schlumberger (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SLB#NYSE">SLB</a>) with a Neutral and lowers the price target from $46 to $44.

Piper Sandler Maintains Neutral on Schlumberger, Lowers Price Target to $44

Macro Economic Events

Econ #s

Economics

Dallas Fed Texas Service Sector Index Of General Business Activity Outlook -19.4 In April Vs -11.3 In March

Dallas Fed Texas Service Sector Revenue Index 3.8 In April Vs 1.3 In March

UBS analyst Curt Woodworth maintains Crown Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CCK#NYSE">CCK</a>) with a Buy and raises the price target from $109 to $114.

UBS Maintains Buy on Crown Holdings, Raises Price Target to $114

JetBlue Airways Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JBLU#NASDAQ">JBLU</a>) shares slipped Tuesday after posting mixed <a target="_blank" href="https://www.benzinga.com/pressreleases/25/04/b45062405/jetblue-announces-first-quarter-2025-results" rel="noreferrer noopener">first-quarter 2025 results</a>.
The airline reported an adjusted loss of 59 cents per share, narrower than the <a target="_blank" href="https://www.benzinga.com/earnings" rel="noreferrer noopener">expected 61 cents loss</a> but wider than last year&#8217;s 43 cents loss. Revenue of $2.14 billion was down 3.1% year over year, just missing the $2.15 billion consensus.
In the first quarter of 2025, JetBlue&#8217;s capacity declined 4.3% year over year, while operating expenses fell 21% year over year to $2.3 billion.
Also Read: <a target="_blank" href="https://www.benzinga.com//node/44671680" rel="noreferrer noopener">Which US Airline Faces The Strongest Industry Tailwinds?</a>
Operating revenue per ASM increased by 1.3% YoY, Operating expense per available seat mile (CASM) declined 17.4% YoY, CASM ex-fuel rose 8.3%, and average fuel price was $2.57 per gallon.
JetBlue&#8217;s premium, international, and loyalty segments remain strong under its JetForward strategy. Premium RASM outpaced core RASM, transatlantic RASM rose 28% despite reduced capacity, and loyalty revenue grew 9% year-over-year.
JetBlue ended the quarter with $3.8 billion in liquidity—41% of trailing 12-month revenue, excluding an undrawn $600 million credit facility.
The operating margin for the quarter improved 24.4 points to (8.2)%, and the adjusted operating margin fell to (8.2%) from (7.1)% a year ago.
JetBlue ended the quarter with $2.97 billion in cash and equivalents.
&#8220;In the first quarter we saw booking strength from January deteriorate into February and worsen into March,&#8221; said Marty St. George, JetBlue&#8217;s president.
&#8220;We expect softened demand for off-peak travel to continue into the second quarter, where the booking curve is more exposed to macro uncertainty and deteriorating consumer confidence. That said, we are committed to our JetForward plan and are encouraged by the resiliency of premium, international, and loyalty revenues &#8211; core components of our long-term strategy,&#8221; added Marty.
JetBlue advanced its JetForward strategy in the first quarter with improved reliability, driving a four-point A14 gain and double-digit NPS growth, saving ~0.75 pts in CASM ex-fuel. Northeast BlueCities showed strong margins, while new product perks and a premium co-branded credit card exceeded expectations. Cost initiatives continued, focused on tech efficiencies and fuel optimization.
Guidance Q2: JetBlue anticipates that in the second quarter of 2025, available seat miles (ASM) are expected to decline (3.5%) – (0.5%) year over year. RASM is predicted to be down (7.5%) &#8211; (3.5%) for the second quarter.
CASM ex-fuel is expected to grow 6.5% &#8211; 8.5%, and Fuel Price per Gallon is estimated to be between $2.25 &#8211; $2.40 for the quarter.
JetBlue anticipates a CapEx of $400 million in Q2 and roughly $1.30 billion in 2025
&#8220;As we continue to monitor the evolving macro backdrop, we are evaluating all levers available to us to boost profitability and preserve cash, including additional capacity reductions, targeted cost savings, and further evaluation of our fleet retirement schedule. Given the macroeconomic uncertainty, we are not re-affirming our prior full-year guidance,&#8221; commented Joanna Geraghty, JetBlue&#8217;s chief executive officer.
Price Action: JBLU shares are trading lower by 3.32% at $3.94 at the last check on Tuesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/earnings/25/04/45067312/paypal-earnings-beat-but-slower-spending-and-checkout-use-weigh-on-results" target="_blank" rel="noreferrer noopener">PayPal Earnings Beat, But Slower Spending And Checkout Use Weigh On Results</a></li>
</ul>
Photo by Coby Wayne via Shutterstock

Guidance

JBLU

JetBlue Warns Of Weak Travel Demand, Pulls 2025 Outlook

Stephens &amp; Co. analyst Andrew Terrell reiterates Preferred Bank (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PFBC#NASDAQ">PFBC</a>) with a Equal-Weight and maintains $91 price target.

Reiteration

PFBC

Stephens & Co. Reiterates Equal-Weight on Preferred Bank, Maintains $91 Price Target

Piper Sandler analyst Christopher Raymond maintains Biogen (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BIIB#NASDAQ">BIIB</a>) with a Neutral and lowers the price target from $135 to $115.

Comments

AlphaPolis Co

Intérêt court

AlphaPolis Co (OTC:APPLF) Stock, Rapport sur les intérêts à découvert

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL